- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$177.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$58,150.00
7D
6.9%
1Y
52.4%
Bristol-Myers Squibb
Market Cap: US$133.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$23.30
7D
6.1%
1Y
n/a
Bristol-Myers Squibb
Market Cap: AR$133.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$35,620.00
7D
6.3%
1Y
68.2%
Bayer
Market Cap: AR$47.8b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$28,160.00
7D
-8.6%
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$7.00
7D
3.7%
1Y
n/a
GSK
Market Cap: US$77.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.65
7D
6.1%
1Y
36.5%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,670.00
7D
4.3%
1Y
n/a
Gilead Sciences
Market Cap: US$177.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$37.95
7D
8.7%
1Y
30.9%
GSK
Market Cap: AR$77.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,910.00
7D
7.0%
1Y
56.0%
Amgen
Market Cap: US$234.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$15.27
7D
6.0%
1Y
54.1%
Biogen
Market Cap: AR$31.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$26,540.00
7D
4.7%
1Y
85.6%
AstraZeneca
Market Cap: AR$187.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$66,225.00
7D
7.6%
1Y
23.1%
Amgen
Market Cap: AR$234.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$23,290.00
7D
6.9%
1Y
77.8%
Vertex Pharmaceuticals
Market Cap: AR$136.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,625.00
7D
9.7%
1Y
65.2%
Biogen
Market Cap: US$31.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$17.40
7D
3.4%
1Y
65.7%
Vertex Pharmaceuticals
Market Cap: US$136.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.72
7D
9.0%
1Y
48.8%
Novartis
Market Cap: US$242.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$41.01
7D
4.0%
1Y
28.4%
Novartis
Market Cap: AR$240.1b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$63,425.00
7D
6.8%
1Y
49.6%
AstraZeneca
Market Cap: US$187.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$43.30
7D
6.7%
1Y
7.6%